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Allergies caused by consumer products and foods 
 
BfR Expert Opinion No. 001/2007, 27 September 2006 
 
Around the world allergies are one of the biggest health problems. They impair the quality of 
life of a large part of the population and have major economic repercussions. The German 
Study on the Health of Children and Adolescents (KIGGS)1 revealed that 40.8% of the 
children examined are sensitised to at least one allergen based on specific IgE antibodies to 
dietary and inhalation antigens. According to this study 16.7% of all children and adolescents 
currently suffer from allergic symptoms or disorders. 
 
The number of allergic diseases is on the increase. In Germany it varies from region to 
region. There are different types of immunological-allergic responses. Airborne allergens and 
foods normally trigger a type I reaction which may manifest in seasonal or year-long common 
cold, nettle rash, bronchial asthma and allergic inflammation of the pulmonary alveoli. In rare 
cases hypersensitivity to certain substances may also trigger immediate life-threatening 
responses (anaphylactic shock). Skin allergies (type IV contact allergies) may be caused by 
various components in consumer products like cosmetics, clothing or toys. The Federal 
Institute for Risk Assessment (BfR) was asked by the Federal Ministry of Food, Agriculture 
and Consumer Protection (BMELV) to present the current level of scientific findings on 
allergies caused by consumer products and foods by way of preparation for the National 
Action Plan on Allergies. 
 
1 Definitions 
 
An allergy is understood to be a hypersensitivity reaction that is triggered by immunological 
mechanisms. 
 
Allergic reactions can manifest as types I to IV allergies (based on the categories of Gsell 
and Coombs). 
 
Type I reactions are IgE-mediated reactions involving the release of mediators (e.g. 
histamine) stored in mast cells, the release of newly formed mediators (e.g. leucotrienes, 
prostaglandins and platelet-activating factor) or the release of cytokines (e.g. IL-3, IL-4, IL-5, 
IL-6, GM-CSF). The clinical symptoms are rhinitis, asthma, urticaria, diarrhoea and 
anaphylactic shock. 
 
The following diagrams illustrate the complex interactions involved in the triggering of an IgE-
mediated type I asthma reaction and an allergic reaction in the gastrointestinal tract. 
                                                
1 KIGGS, conducted by the Robert Koch Institute, http://www.kiggs.de/ 
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Figure 1:  Asthma induction2 
 
  
 
(Terms in figure 1 in clockwise ordern) 
Allergen, Smooth muscle, Eosinophile, B-lymphocyte, Mast cell, Monocyte, Macrophage, 
Epithelial cells, Dendritic cell) 
 
(Subtitle in figure 1) 
Cytokine network in eliciting asthmatic response. (According to [2]; TNF: tumour necrosis 
factor, IL: interleukine, GM-CSF: granulocyte macrophage colony-stimulating factor, 
RANTES: regulated on activation T-cell expressed and excreted; MCP: monocyte 
chemotactic protein, TARC: thymus and activation regulated chemokines; Th: T helper cell. 
 
Figure 2:  Allergy in the gastrointestinal tract3 
 
 
                                                
2 taken from: M. Schmidt (2006): Asthma bronchiale, Der Internist 47, 835-852, according to Barnes 
PJ (2003), Pathopysiology of asthma. Eur Respir Mon 23: 180-194. 
3 Taken from: Lecture by Professor Vieths, PEI, during the seminar “Assessment of the Allergenicity of 
Food Ingredients including Novel Foods at BfR on 12 September 2006.” 
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Type II reactions are antibody-mediated cytotoxic reactions. The cytotoxic effect results 
from activation of complement, by binding to the Fc receptors of killer cells and / or the 
promotion of immunophagocytosis. Type II reactions play a role in cytotoxic reactions 
affecting blood cells/cells of bone marrow, liver and thymus. 
 
Type III allergies lead to glomerulonephritis, arthralgia, urticaria, and sometimes also to 
cytopenia. Immunocomplex responses are involved here in which polyvalent antigens lead to 
cross-linkage with antibodies and the antibodies formed are able to activate the complement 
system. When the complexes reach the tissue, localised inflammation is induced (Arthus 
phenomenon). If the complexes remain in the bloodstream, they can agglomerate in tissues 
where physiological filtration processes take place, for example in renal glomeruli. 
 
Type IV allergies are not antibody-mediated reactions. Type IV reactions are triggered by T 
cells on whose surface an antigen is bound to receptors. Together with MHC II structures, 
CD4 cells are activated. In the context of the MHC I structures this leads to an activation of 
CD8 cells. Activated CD4 cells may release pre-inflammatory cytokines (IFNγ, GM-CSF, 
TNFβ, IL-3, -4, -5, -8) whereas CD8 cells have a cytoxic effect on antigen-carrying cells. 
Contact sensitivity is the most well known example of an allergic type IV reaction. 
 
Allergens are antigens that stimulate the immunologically induced hypersensitivity. They are 
proteins which often possess a carbohydrate side chain. 
 
Atopia is the term used to describe an individual or a familial predisposition to produce IgE in 
response to small doses of an allergen. The typical manifestations are asthma, 
rhinoconjunctivitis or eczematous dermatitis. 
 
Anaphylaxia is a severe life-threatening generalised or systemic hypersensitivity reaction 
which may be triggered by allergic or non-allergic (so called pseudo-allergic) reactions. It 
may be fatal. There are reports of reactions to peanuts with fatal consequences. 
 
The terms used below are based on the proposals of the World Allergy Organization, 
Nomenclature Review Committee (Johansson et al., 2004) and the European Academy of 
Allergy and Clinical Immunology (Johansson et al., 2001). According to these definitions all 
food intolerances come under the generic term “food hypersensitivity”. This can be broken 
down into allergic and non-allergic hypersensitivity (see Figure 3). 
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Figure 3:  Differences between allergic and non allergic hypersensitivity 
 
 
  
Allergic hypersensitivity is the term used to describe objectifiable and reproducible 
symptoms or signs caused by exposure to a specific stimulus at a dose which would be 
tolerated by healthy individuals. 
 
In the case of non-allergic hypersensitivity immunological mechanisms are not detectable. 
The clinical term used for this is “pseudo-allergy“. 
 
In the following text as a rule the term allergic hypersensitivity reactions is used. Substances 
from consumer products may cause allergic contact dermatitis when they come into contact 
with the skin (type IV allergy). Substances released into the air from products may also lead 
to allergic hypersensitivities through skin contact (type IV allergy) or through contact with the 
respiratory tract (type I allergy). Substances in foods may also induce oral sensitisation (type 
I allergy). Non-allergenic reactions to food (ingredients) and reactions to food additives are 
also mentioned. These non-immunological reactions encompass the so-called pseudo-
allergic reactions as well as reactions caused by biogenic amines or reactions due to enzyme 
deficiencies. In most cases the exact mechanism that led to non-immunological reactions is 
not known (EFSA, 2004). 
 
The clinical appearance of pseudo-allergic reactions is similar to that of immune-mediated 
responses. Severe, sometimes life-threatening symptoms may occur. In both cases the 
same mediator systems (for instance mediators from tissue mast cells like histamine and 
leucotrienes) are involved. Whereas the mediator release is triggered in the case of the 
immune-induced response by an antigen-antibody reaction at the mast cell membrane, the 
mediators in the case of the pseudo-allergic reaction are released by pharmacological 
mechanisms (Kreft et al., 1995). The so-called pseudo-allergy is non-specific for the 
causative agent. It may occur without prior sensitisation which means at the first contact. 
Pseudo-allergic reactions are generally triggered by low molecular substances which occur 
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naturally in or can be added to foods. Reports of hypersensitivity reactions linked to natural 
food ingredients or food additives, have been assessed by the former Scientific Committee 
on Food of the European Commission (SCF 1982, 1995) as well as by the Scientific Panel 
on Dietetic Products, Nutrition and Allergies (NDA) of the European Food Safety Authority 
(EFSA) on several occasions (EFSA, 2004). 
 
2 Consumer products 
 
Substances in products that come into contact with the skin play an important role as 
exogenous factors in the triggering of allergic contact eczemas (type IV allergies) at home 
but also at work. Occupational skin diseases have headed the list (approximately 25%) of all 
reported occupational diseases for many years in Germany and in other European countries. 
 
The most important skin-contact products for consumers are cosmetics and clothing textiles. 
However, other products that have intensive skin contact like shoes, gloves and toys are also 
to be taken into account. Special mention should be made of tattoos where the skin’s barrier 
function is switched off. Effective prevention is possible through the identification and 
elimination or limitation of the allergens. For instance, reducing exposure to nickel in costume 
jewellery (see below) in Denmark and Germany has led to a major drop in nickel allergies in 
young women and men (Jensen et al., 2002). From the regulatory angle appropriate labelling 
of allergens is customary in cosmetics so that sensitised individuals can avoid skin contact. 
 
Besides the substances which are taken up exclusively through skin contact, fragrances are 
also of importance. They are used in various ways in cosmetics and commodities including 
detergents and cleaning products and are taken up via the respiratory tract. Up to now it is 
unclear whether skin sensitising fragrances can lead, in conjunction with inhalation exposure, 
to respiratory allergies or to allergic contact eczemas. There have been reports that highly 
sensitive groups like asthma patients, atopics and individuals whose symptoms are linked to 
multiple chemical sensitivity and the sick building syndrome showed hypersensitivity 
reactions to fragrances. However, in the case of the two latter disorders opinions differ as to 
whether a primarily toxicological mechanism is involved. A background paper by the Federal 
Environmental Agency (UBA) refers to an epidemiological research project of the Information 
Network of Departments of Dermatology (IVDK, Göttingen) that examines reactions to 
fragrances (UBA, 2006). Furthermore, the influence of passive smoking on asthma 
development in children is of importance. 
 
2.1 Epidemiological findings 
 
The Information Network of Departments of Dermatology (IVDK) evaluates data from 40 
dermatology departments in Germany, Austria and Switzerland. At regular intervals it draws 
up lists of allergens ranked by prevalence (Schnuch et al., 2004; Straff and Schnuch, 2006). 
For instance based on the data from 1999, a manifest allergic contact eczema was 
diagnosed based on a positive epicutaneous test reaction in 1,648 out of 9,266 patients 
tested in dermatology departments. Depending on the model of extrapolation from the tested 
patient cohort to the normal population, this corresponds to an incidence (rate of new cases) 
of between three (medium case scenario) and seven (worst case scenario) cases per 1,000 
a year. However, the incidences identified in selected professional groups are far higher. 
 
There are only rough estimates of the incidence of allergic contact eczema in the general 
population. So far, no comprehensive studies have been conducted (Schnuch et al., 2004). 
In the Health Survey 2000 non pre-selected patients were questioned by a dermatologist 
about the occurrence of an allergic contact eczema. Based on these survey results a lifetime 
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prevalence of around 15% and an annual prevalence of approximately 7% were identified 
(Hermann-Kunz, 2000). By contrast, based on epicutaneous tests conducted between 1992 
and 2000 in a total of 78,067 patients, IVDK identified, using the different extrapolation 
models, a 9-year prevalence of 7% (medium case scenario) and of 16.6% (worst case 
scenario) for the overall population in the Federal Republic of Germany (Schnuch et al., 
2004). The analysis of sensitisations in this patient cohort, extrapolated to the total 
population, led to a ranking of substances which triggered sensitisation most frequently. 
Nickel was at the top of the list (2.3%), followed by a fragrance mixture (1.8%), Peru balsam 
(1.3%), p-phenylene diamine (0.7%) and potassium dichromate (0.6%). In 2004 the ten most 
frequent triggers of positive test reactions in patients with allergic contact eczema (hit list) 
were nickel, fragrance mixture, Peru balsam, cobalt chloride, potassium dichromate, 
colophonium, amerchol L 101 (wool wax alcohol), p-phenylene diamine, mercury amide 
chloride and methyl dibromoglutaronitrile/phenoxyethanol (Oppel und Schnuch, 2006). 
 
2.2 Dose-response relationship 
 
Risk assessment only permits quantitative statements to a very limited degree, including 
dose-response relationships and threshold levels when it comes to contact allergies and 
consumer products. The problem already starts with the definition of the exposure dose in 
humans. Links between the content of a substance in the product (concentration) and 
exposure are only possible in the case of preparations like paints, detergents and cosmetics. 
However the conditions of use must also be taken into account. In the case of consumer 
products like clothing and toys, it is only the proportion of the substance released from the 
product (migration) that is important for exposure assessment. At the present time, there are 
only few generally accepted methods (e.g. for phthalates in toys) for measuring migration 
and scarcely any data are available from appropriate measurements. A further problem is 
that the measurement data are not necessarily suitable for exposure assessment. The goal 
of the research project Compilation, analysis and evaluation of data and methodologies to 
characterise qualitatively and quantitatively human exposure to chemicals released from 
consumer products/articles (“ChemTest”) is to obtain suitable data and methods. BfR is 
involved in this project. 
 
Moreover, for the purposes of a quantitative risk assessment, detailed knowledge is needed 
about the dose-response relationships in humans  for both the sensitising and allergy-
inducing effect of the substances concerned. When it comes to allergies special attention 
must be paid to the group of already sensitised individuals. Up to now, data on dose-
response relationships have only been available for a few model substances. The 
established test methods in animal experiments normally only lead to semi-quantitative 
results. More dose-response relationships that also permit quantitative statements or render 
these more reliable could become available in the future through increased use of the lymph 
node test. 
 
2.3 Important substance groups 
 
The potential sources of exposure of the main allergenic substances in consumer products 
are presented below (selected by Schnuch et al., 2004): 
 
Nickel:  Nickel is by far the most important contact allergen both around the world and in 
Germany. According to estimates, up to 4.5 million German people are sensitised to this 
allergen (Schnuch et al., 2002). Exposure sources are jewellery, piercings and clothing 
accessories. For individuals who are already sensitised to nickel, oral exposure for instance 
from cooking utensils and electric kettles, may also be relevant (EFSA, 2006). 
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Fragrances:  There are more than 5,000 fragrance substances. They are frequently used as 
mixtures, particularly in cosmetics (perfumes, shampoos, creams, shower gel, toothpaste), 
household products (for instance in room fresheners and in carpet shampoos), textiles, 
shoes, toys, etc. 
 
Peru balsam:  Peru balsam is a natural product which is made from the wound exudation of 
the Peru balsam tree. It is used as a fragrance in cosmetics (soaps, shampoos, lipsticks), 
shoes and tobacco. 
 
Chromium and potassium dichromate:  Chromium or potassium dichromate is found in 
cement and other building materials, glazings, paints, leather clothing, leather gloves and 
leather shoes as well as in material for uniforms. 
 
Colophonium:  Colophonium is a natural product made from the resin of conifers. It is used 
amongst other things for glues, paints and printing inks. 
 
Methyl dibromoglutaronitrile (MDBGN):  This substance is used as a preservative in 
cosmetics (now banned), detergents and ultrasound gel. 
 
p-Phenylene diamine:  p-phenylene diamine is used in hair dyes, part of disperse dyes in 
textiles, antioxidants in rubber and in paints/varnishes, plastics and as a henna additive 
(temporary tattoos). 
 
Thiurames:  The substance mixture is used as a vulcanisation accelerator in rubber 
products like rubber gloves, spray and adhesive plasters or insect repellents. 
 
(Chloro)methyl isothiazolinone (isothiazolinone mixture CMI/MI):  This substance is 
used as a preservative in glues, waxes, paints/varnishes, leather clothing, wood 
preservatives, mixed water dyes and cosmetics. 
 
Turpentine oil:  Turpentine oil is known as a solvent and diluting agent in varnishes, paints, 
shoe polish, resins, building materials, etc. There have been reports of a cross-allergy 
between turpentine oil and various fragrances and tea tree oil. 
 
Formaldehyde or formaldehyde liberators/resins:  This substance is used as a 
preservative in cosmetics, wash-and–wear textiles, paint/varnishes and chipboard. 
 
 
2.4 Relevant products and materials 
 
The following section describes important product areas for the triggering of allergies: 
 
Clothing textiles 
According to findings of the BfR Textile Working Group, between 1 and 2% of contact 
allergies in German dermatological clinics are triggered by textiles. The textile auxiliary 
catalogue contains approximately 7,000 preparations of textile auxiliaries and finishing 
agents. Furthermore, there are colourants (pigments or dyes). Roughly half of the 4,000 
colourants are azo dyes. In some cases, carcinogenic and allergenic amines may be 
released from them during metabolism or on the skin. When it comes to the triggering of 
allergies, the highly sensitising disperse dyes like Disperse Blue 106 and 124 are of 
importance. They often occur together. After azo cleavage Disperse Blue 106 and 124 may 
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also release the highly allergenic substances p-phenylene diamine or p-aminoazobenzene. 
Around two thirds of all textile-related cases of allergy are attributed to disperse dyes (Hatch 
and Maibach, 1995). Other important allergens in clothing are potassium dichromate (leather 
clothes) formaldehyde-releasing resins (wash-and-wear finish) and rubber chemicals like 
thiurames, dithiocarbamates or benzothiazoles (in rubber bands) (Schnuch et al., 2004). 
 
Leather clothing including gloves 
Potassium dichromate is one of the most important contact allergens. Azo dyes as well as p-
tert-butyl phenol formaldehyde resin from adhesives may play a role as allergens in shoes. 
 
Cosmetics 
High sensitisation rates were identified for the following ingredients both for leave-on 
products on the skin and for cosmetics which are rinsed off:  fragrance mixture, Peru balsam, 
MDBGN, wool wax alcohols, CMI/MI etc. (Schnuch et al., 2004). In the case of hair products 
whose ingredients can lead to neck, head and face eczemas in consumers, besides 
fragrances and preservatives (MDBGN, CMI/MI), the most apparent are mainly typical 
“hairdresser substances” like ammonium per sulphate but also p-phenylene diamine and p-
aminophenole as precursors or degradation products of hair dyes and thiurames as rubber 
ingredients (Schnuch et al., 2004). 
 
The competent scientific body of the European Commission (SCCNFP/SCCP) assessed 
specific fragrances because of their diverse application areas in cosmetics and other product 
groups. In its expert opinion dated 25 September 2001, it strongly recommends restricting 
the use of these, in some case highly sensitising, substances or imposing specific 
requirements on their use. 
 
Hair dyes were examined by the Scientific Committee on Consumer Products (SCCP) of the 
European Commission. Some of the substances used were found to have highly sensitising 
properties. Appropriate labelling provisions are currently in place. 
 
Tattoos, permanent make up and henna tattoos 
According to IVDK, skin reactions in conjunction with tattoos are rare but are as a rule severe 
if they occur. Allergic reactions play the largest role. Besides metal-containing substances in 
dye mixtures a key role may also be played by the sensitising dyes as well as by amines 
which may occur as impurities or as cleavage products in tattooing agents. 
 
Henna tattoos also called temporary tattoos or temptoos are a major problem when it comes 
to allergies. Because in this case, the dye mixture is applied to the skin, it is considered to be 
a cosmetic. Henna tattoos are frequently darkened with the sensitising p-phenylene diamine 
(black henna). In the EU p-Phenylene diamine is only permitted in cosmetics for use in 
oxidation hair dyes. Hence, its use in henna tattoos is prohibited. Nevertheless black henna 
is frequently used, particularly for body painting in children. Numerous individual case studies 
in the scientific literature confirm allergic reactions in conjunction with henna tattoos. A recent 
publication from Denmark describes serious skin reactions to hair dyes in eight children 
under the age of 16, of whom six had already suffered a reaction to black tattoos (Sosted et 
al., 2006). As henna tattoos are mainly offered on markets or at holiday destinations, 
consumer awareness should be raised about this issue. 
 
Toys 
The Committee on Cosmetic Products and Non-Food Products (SCCNFP) of the European 
Commission had already proposed in its expert opinion in 1999 that manufacturers should 
refrain from using sensitising fragrances in toys on grounds of precautionary health 
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protection. Many of these sensitising fragrances were identified and quantified in seven out 
of ten products examined in the study presented in Denmark “Mapping of perfume in toys 
and children’s articles” (ENTR/TOYS/2006/36, dated 27 April 2006). Several non-sensitising 
fragrances are available as a substitute. 
 
Room fresheners 
A report by the Scientific Committee on Health and Environmental Risks (SCHER) of the 
European Commission is available on the emission of chemicals from air fresheners. This 
body sees a lack of clarity concerning the associations between disease symptoms and the 
emissions from air fresheners which have been observed particularly in highly sensitive 
groups of individuals (SCHER, 2006). 
 
Rubber products 
Two forms of allergies are generally known in conjunction with rubber products. The classical 
rubber allergy is a type IV allergy and is triggered by skin contact with the processing aids 
like vulcanisation accelerators (e.g. mercaptobenzthiazol). In recent years special attention 
has, however, also been paid to type I allergies (immediate type) which are triggered by 
natural latex components (proteins). This form of allergy has been observed in particular in 
children who have had several operations (intensive mucosa contact with rubber medical 
devices) and in hospital staff (use of powdered surgical gloves). Aerogenic exposure seems 
to be particularly important in the case of powdered gloves. The BfR Plastics 
Recommendation XXI, Consumer Products Based on Natural and Synthetic Rubber, 
contains the following passage:  In order to prevent the risk of allergies, the content of 
soluble proteins is to be reduced to a minimum in consumer products in the special category 
and in other consumer products in accordance with §2 (6) Nos 3-6 Food and Feed Act 
(LFGB). In the case of products made from natural rubber latex the consumer products or 
their packaging must carry the following wording:  “Natural rubber latex has been used in the 
production of this product which may cause allergies.” 
 
Passive smoking 
The report by the Surgeon General dated 27 June 2006 sums up the current level of 
scientific knowledge on the health risks from passive smoking. Besides other risks, it 
confirms that children exposed to passive smoking are more at risk of developing asthma, 
too (Department of Health and Human Services, 2006). Several studies from various 
countries all show that parental smoking increases the prevalence of asthma and respiratory 
symptoms like coughing and rhonchus in children under the age of eleven. A meta analysis 
of these studies revealed a statistically significant link between the number of smokers and 
the prevalence of the occurrence of the symptoms (odds ratio 1.47, both parents smoke). 
The report comes to the conclusion that the data sufficiently prove a causal relationship 
between parental smoking and asthma in children. 
 
2.5 Research 
 
The following research topics are currently being addressed by BfR: 
 
? Toxicity of chemicals in consumer products and cosmetics in human keratinocyte 
cultures 
? Studies on the allergenic potential and on the skin penetration of constituents from 
consumer products and cosmetics 
? Studies on the metabolism of azo dyes in clothing and cosmetics 
? Toxicological studies on substance mixtures from consumer products 
? Cleavage of azo dyes by bacteria in the human skin in vitro 
   Page 10 of 29 
Federal Institute for Risk Assessment 
 
Need for experimental research: 
 
? Support for the development of methods to measure exposure from consumer 
products 
? Support for dermato-toxicological research projects (test for sensitising properties, 
test on skin penetration, test on dermal exposure, test on systemic availability and 
effect of tattoo dyes) 
? Further development of existing test systems or development of new in vitro tests for 
skin sensitisation including molecular mechanisms of action (expression analysis / 
proteomics, morphological and molecular indicator tests). 
 
Need for epidemiological research: 
 
? Development in and continuous support for epidemiological studies on contact 
allergies in Germany with a focus on specific products (IVDK) 
? Further studies and definitive clarification of the question whether and, if so, how 
exposure to passive smoking encourages asthma development in children. 
 
2.6 Summary:  Consumer products 
 
It is difficult to say whether there is a growing trend towards contact allergies caused by 
consumer products. On the one hand, product ranges and consumer behaviour change very 
quickly; on the other, the identified risks are regularly reduced through intervention 
measures. However, the substitutes, as numerous examples have shown, can lead to new 
risks. 
 
Quantitative statements on risk assessment along the lines of dose-response relationships 
and thresholds are only possible to a very limited degree in the area of “contact allergies and 
consumer products”. 
 
Effective prevention of contact allergies is based on two things. First of all mention should be 
made of the testing of substances used in consumer products. This applies in particular to 
products which come into contact with the skin. The established tests can identify allergens. 
The lymph node test allows the classification of substances by potency. Human experience 
is also essential. With IVDK Germany has an effective system; however, its contribution to 
consumer health protection could and should be considerably improved. The methods 
mentioned above and IVDK are important sources of information for risk assessment and the 
resulting management options for regulation. Experience has shown that exposure-reducing 
measures (constraints on applications or concentrations, warnings for risk groups) effectively 
influence allergic incidents in the field of contact allergies. In the case of nickel, regulatory 
measures have reversed the trend. Labelling regulations for allergenic fragrances have been 
introduced for cosmetics and detergents. Regulations are currently being prepared for 
chromate in leather clothing and tattoos. 
 
BfR believes there is a considerable need for research in the areas of exposure (release of 
substances), dermato-toxicology (method development) and epidemiology. 
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3 Food 
 
3.1 Food and food ingredients 
 
3.1.1 Overview of prevalence 
 
The prevalence of food-induced allergies in the general population is estimated to be 
approximately between 1 and 3% of adults and 4 and 6% of children (EFSA, 2004) and up to 
8% of children (Boden et al., 2005; Lorenz et al., 2001). Although in principle almost all foods 
can trigger isolated cases of food allergies, only relatively few foods are of particular clinical 
importance. For instance 75% of food allergy reactions in children occur in conjunction with 
the consumption of eggs, peanuts, dairy milk, fish and certain types of nuts whereas around 
50% of allergies of this kind in adults can be traced back to fruits like kiwi, banana, apple, 
pear, plum and vegetables like carrots and celery as well as certain nuts and peanuts (EFSA, 
2004). 
 
A study conducted in Berlin involving a representative random sample of the population 
supplied concrete data on the incidence of food allergies (Roehr et al., 2004; Zuberbier et al., 
2004). It should, however, be pointed out that these data apply solely to Berlin. It is not 
possible to apply them to the general population as the type and prevalence of 
hypersensitivity reactions of a population to foods depend on eating habits, climate and 
environment. This study is the first of its kind in the world to examine the prevalence of 
hypersensitivity reactions to foods in a non-selected random population sample while 
applying a precise diagnostic regimen. According to this study the ratio of reported to 
clinically proven cases of hypersensitivity is approximately 10:1 (Roehr et al., 2004). There is 
a similar situation in other countries like the United Kingdom and Denmark (Pereira et al., 
2005; Osterballe et al., 2005; Venter et al., 2006). 
 
Given the lack of longitudinal studies and reliable derived data, a sound scientific answer 
cannot be given to the question whether hypersensitivity reactions to foods have increased in 
recent years. The number of foods for which hypersensitivity reactions have been reported 
has increased. This may be due to the broader range of foods on offer, increased awareness 
or improved diagnostics. Ellman et al. (2002) reported for the United Kingdom that the 
sensitisation rate to foods had not increased in two groups of children and adolescents with 
atopic dermatitis, who were examined and then re-examined ten years later. They also 
reported that the foods concerned had largely remained the same with the exception of 
increased sensitisation to milk and peanuts. 
 
3.1.2 Existing labelling provisions for the main allergens 
 
Annex IIIa to EU Directive 2000/13/EC lists the foods that trigger allergies and certain 
intolerances most frequently. These so-called main allergens – “the allergenic dozen” – are 
linked to the most frequent allergies to foods in terms of numbers and must be indicated on 
the labels of (pre-packaged or mainly processed) foods:  gluten-containing cereals (wheat, 
rye, barley, spelt, kamut or their hybridised strains, crustaceans, eggs, fish, peanuts, 
soybeans, milk, shell fruit (almonds, hazelnuts, walnuts, cashew nuts, pecan nuts, brazil 
nuts, pistachios, macadamia nuts, Queensland nuts), celery, mustard, sesame seeds and 
products derived from them as well as sulphur dioxide and sulphites at concentrations of 
more than 10 mg/kg or 10 mg/l expressed as SO2 (EU Directive 2003/89/EC, amending 
Directive 2000/13/EC). This selection of ingredients that have to be listed on the label 
corresponds to the most frequent food allergies and intolerances in Europe. As some 
derivatives of known food allergens may not trigger any allergic reactions, certain exceptions 
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were formulated which are valid up to November 2007 (Annex to Directive 2005/26/EC of the 
Commission of 21 March 2005 establishing a list of food ingredients or substances 
provisionally excluded from Annex IIIa of Directive 2000/13/EC). To reflect the latest scientific 
findings, the Directive is to be continuously re-examined and, if necessary, updated. 
 
The above-mentioned labelling provisions mainly refer to packaging labels on ready-to-eat 
products. Exceptions are so-called “loose products” like bread and bakery products, sausage 
and cheese which are sold over the counter in bakeries, butchers shops, canteens, at weekly 
open air markets etc. by sales staff to the consumer. This wording need not appear either on 
pre-packaged food like freshly prepared salads, which are prepared at the point of sale for 
immediate sale to the consumer and are handed over to the consumer by the sales staff. 
Foods, however, must be labelled if the customer purchases a salad, etc. in a self-serve 
outlet. 
 
There are currently no limit values in Germany or the EU for mandatory listing of allergenic 
components on the label. Allergens which unintentionally reach the food need not be labelled 
either. The causes of unintentional contamination with allergenic (otherwise mandatory 
labelled) components (cross contamination) are mainly the (unwitting) use of contaminated 
ingredients and the carry-over of contaminated ingredients into the production process as a 
consequence of inadequate rinsing or inadequately separated production sections. Hence for 
reasons of product liability some manufacturers use the wording “May contain traces of XYZ 
(XYZ = allergens, e.g. hazelnuts)” in the labelling of their products. 
 
When the wording “May … contain” is merely used for prophylactic reasons because suitable 
measures to reduce or even prevent cross-contamination would make production more 
expensive, this is not really in the interest of consumer protection as growing use of this 
wording further reduces the choices available to allergy sufferers. At all events, it is 
recommended that manufacturers quantitatively determine the degree of contamination and 
take technical steps to prevent it. 
 
3.1.3 Examples of other relevant allergens that as yet need not be listed on labels 
 
Lupins 
There have been cases of hypersensitivity reactions to lupins and products made from lupins 
like lupin flour which have been reported several times in recent publications. Lupin products 
include lupin flour, which is used for the production of gluten-free bakery products and meals 
for the dietetic treatment of patients suffering from coeliac disease as well as numerous 
ready-to-eat products (quark, tofu, sausages, liquid spices, schnitzel, vegeburgers, spreads, 
pasta, all types of bakery goods, coffee substitutes) to which lupin flour, lupin protein 
concentrate, lupin bran or lupin fibre concentrates are added. These products are mainly 
intended for vegetarians and are sold in health food stores. There are no exact figures on the 
frequency of use or level of consumption of lupin products. Cases of hypersensitivity 
reactions to lupin flour and cross-reactivities with peanut allergies have been documented 
(e.g. Radcliffe et al., 2005;  Wüthrich et al., 2004;  Smith et al., 2004;  Faeste et al., 2004). 
Lupin flour is normally listed as an ingredient in bakery products / baking mixtures and ready-
to-eat products which are sold to coeliac disease patients and vegetarians. However, it may 
not always be listed when small amounts of lupin products (flour or protein / fibre 
concentrates) are used because of their emulsifying properties instead of food additives. 
 
It would be appropriate and desirable for consideration to be given to the mandatory labelling 
of lupin products as ingredients because of the small amounts that suffice to trigger allergic 
symptoms and the possible severity of the symptoms of a lupin protein allergy even though, 
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at the present time, the prevalence of lupin protein allergies is nowhere near as high as that 
of peanut or soybean protein allergies. BfR refers to the EFSA Opinion on Lupins (EFSA, 
2005). 
 
Seafood 
Seafood is seen as a relevant allergenic food (Osterballe et al., 2005; Lorenz et al., 2001) for 
which mandatory labelling is in place in Australia and New Zealand in addition to the known 
main allergens mentioned above (Boden et al., 2005). 
 
Molluscs are a large and diverse group of seafood that include roughly 100,000 species 
which live in salt water, fresh water and on land. Some molluscs are an important source of 
food. They are used as ingredients in processed foods like soups and sauces and in 
products like surimi. There have been reports of food allergy reactions to various molluscs 
like snails, oysters, mussels, clams, squid, abalones and octopus which were, in some 
cases, life-threatening. The prevalence of self-reported mollusc allergies extends from 
approximately 0.15% (4 in 2716) in school children in France up to around 0.4% (or 20% of 
all cases of seafood allergies) in a household study involving 14,948 people in the USA. 
 
BfR considers that reflections on mandatory labelling for molluscs as ingredients in foods are 
called for and refers to the EFSA Opinion on the Assessment of Molluscs for Labelling 
Purposes (EFSA, 2006). 
 
Further foods or ingredients 
Other foods or ingredients which have been described as triggers of hypersensitivity are 
carrots, cucumber, oranges, pineapples, tomatoes, raw potatoes (Osterballe et al., 2005) as 
well as stone and pomaceous fruit like peaches, kiwis, mangoes, and lychees (Besler, 2001). 
Peas are also included amongst the more important possibly allergenic foods (DGE, 2002). 
 
Celery is one of the main allergens. It triggers allergies relatively frequently and plays a major 
role in the mugwort-celery-carrot-spice syndrome (Besler, 2001). There have also been 
reports of allergic reactions to various spices and herbs like aniseed, coriander, caraway, 
chamomile and paprika (Besler, 2001). Curry, pepperoni, parsley, oregano, green pepper 
and ginger may also be allergenic ingredients (Osterballe et al., 2005). 
 
Cross-reactions 
When considering foods and ingredients that can lead to intolerance reactions, possible 
cross-reactions should be taken into account. Cross-reactions are based on structural 
similarities between the allergenic proteins of various foods or between pollen and food 
allergens. They extend the sensitisation spectrum in humans. A cross-reactivity has been 
observed between an allergy to latex and certain fruits like avocados, potatoes, bananas and 
tomatoes (Samartin et al., 2000). Up to 80% of people who are sensitised to birch pollen also 
have a cross-reactivity to foods like apples, cherries, brazil nuts, celery, hazelnuts, kiwi, 
oranges, tomatoes, carrots and peaches (Osterballe et al., 2005;  Samartin et al., 2000;  
Besler M, 2001;  Burks/Ballmer-Weber, 2006) and, in some cases, to soya as well. In some 
cases allergens of fresh fruit and vegetables have proved to be heat labile which means that 
the allergenic potential can be reduced by heating the food. 
 
The most frequent clinical manifestation of a pollen-associated food allergy is the oral allergy 
syndrome (OAS) which occurs directly after or within 30 minutes of eating the food. This 
mainly involves itching and swelling of varying degrees of the oral mucosa, lips and tongue, 
but severe systemic manifestations are also possible (Ballmer-Weber/Wüthrich, 2001;  
Vickerstaff Joneja, 1999;  Burks/Ballmer-Weber, 2006). 
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Non-immunologically mediated food intolerances 
Non-immunologically mediated food intolerances caused by a real or induced enzyme 
deficiency (e.g. lactase deficiency) or pseudo-allergies after mediator release are not 
triggered by the immune system. Other pseudo allergic phenomena, induced for instance by 
salicylates or the effects of certain biogenic amines like histamine, serotonin and tyramine 
are also not caused by the immune system (Raithel et al., 2002). Dietary enteral histamine 
intake (for instance from certain types of cheese, anchovies, tuna fish) may lead to food-
induced histaminosis with gastrointestinal symptoms, headache, flush, tachycardia and a 
drop in blood pressure. Fresh foods contain hardly any or only low amounts of biogenic 
amines as long as they are not exposed to any microbial influence. Fermented foods of plant 
and animal origin contain varying amounts of amines depending on the degree of processing 
and refining. Examples that can be mentioned here are cheese, in particular cheddar and 
blue cheese, sauerkraut and wine. Depending on the hygiene conditions (production, 
transport, warehousing, processing) excessive bacterial contamination may lead to spoilage 
processes with an ensuing increase in the amine content. High protein foods like fish, meat 
and sausages may be particularly affected (Siedentopp, 1997). 
 
3.1.4 Summary 
 
There are no robust prevalence data that would permit a ranking of the above-mentioned 
possible allergens. Any prioritising of the main allergens by the severity of their allergy-
inducing potential is difficult as sensitivity varies considerably between individuals. 
 
3.2 Contribution of pesticides and contaminants to the development of an allergy 
 
Various organophosphates (diazinon, dichlorvos, fluazinam, parathion) are indicated as 
triggers of asthma at the workplace (www.asmanet.com). So far there have been no reports 
of pesticides and contaminants that have triggered allergies via the oral route. 
 
3.3 Prevention measures, particularly in infant and child nutrition. 
 
According to estimates, an atopic constitution – a genetic predisposition to sensitisation by 
allergens and to the production of IgE antibodies – contributes to between 70 and 80% of the 
manifest IgE-mediated allergic diseases. 
 
Breastfeeding and an avoidance of exposure to tobacco smoke during pregnancy and after 
birth are recommended as the main prevention measures (Johansson und Haahtela, 2004). 
Breastfeeding does not have a 100% preventive effect; this seems to be restricted to allergic 
dermatitis and seems to merely postpone manifestation. 
 
Exclusive breastfeeding and the avoidance of complementary food and dairy milk in the first 
four to six months of a baby’s life are recommended for all children, irrespective of their 
genetic predisposition. The breastfeeding mother does not need to keep to an elimination 
diet except in the rare cases in which a food allergy has been identified in the breastfed 
infant by means of reliable diagnostic methods. 
 
If an infant is not breastfed and there is a family history of allergic diseases in first-degree 
relatives, the infant should only be given formula with proven reduced allergenicity for at least 
four to six months (Muraro et al., 2004a, b, c; Halken, 2004). The hypo-allergenicity of these 
foods should not only be determined by characterising protein segments using chemical or 
immunological methods but should also be confirmed in controlled clinical trials. There are 
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scarcely any robust data on the recommended dietary regimen in the second half of a baby’s 
first year of life in the case of a family predisposition. The gradual introduction of new foods 
under observation is recommended whereby foods (eggs, soya, fish, nuts, peanuts) which 
cause allergies very frequently in early childhood, should not be given to the child before it 
reaches the age of two. 
 
A newborn baby has the most intensive contact with allergens via the gastrointestinal tract. In 
simple terms, there are two possible reactions:  sensitisation or the development of an oral 
tolerance with an immunological response that is not characterised by inflammatory tissue 
messenger substances. So far, it has not been possible to identify the underlying 
mechanisms. 
 
Besides a genetic predisposition (41 to 70% of all infants with a dairy milk allergy come from 
families with atopic diseases compared with 29 to 35% of non-allergic infants), the 
functioning immunity of the mucosa of the gastrointestinal tract plays a decisive role in 
protection against allergies. This mucosa-associated immune system consists of a non-
specific (mucus) and a specific component with the capacity for immune exclusion. Immune 
exclusion for instance takes place through secretary antibodies or suppression mechanisms 
whereby local or systemic sensitisation to harmless food antigens is avoided. These specific 
mechanisms are not fully developed at birth. Their development depends on adequate 
microbial stimulation and also on the time and level of the first contact with food antigens 
(Hauer, 2006). One highly promising research area is the influence of food on the intestinal 
microbiota of infants (Penders et al., 2006) and the administration of probiotic bacteria in the 
first six months of life in order to stimulate the development of the immune system in the 
expectation of effects on the onset of allergic diseases. 
 
In the case of a proven food allergy (open exposure, DBPCFC, skin tests, serology), the 
standard treatment is still a diet in which the foods which have been proven to cause the 
allergy, are left out. 
 
The specific induction of oral tolerance in individuals with an existing food allergy could be an 
alternative to the strict elimination diet which often constitutes a major burden for the people 
affected (Staden et al., 2006). On the basis of specific oral tolerance induction, concepts 
could be developed for the targeted primary prevention of allergic diseases (Strid et al., 
2004) if the immunological processes involved could be elucidated, if the necessary allergen 
doses could be determined and if the decisive molecules for the production of oral tolerance 
could be identified (Niggemann et al., 2006). For some years now experiments have been 
under way to induce a specific oral tolerance by slowly increasing intake (may take up to one 
year) of the foods that trigger the allergy symptoms and, in this way, bring about a 
supposedly active suppression of the immunological (IgE mediated) reaction. However, it has 
been shown that regular allergen intake is necessary to maintain tolerance (Rolinck-
Werninghaus et al., 2005). In the case of pollen-associated food allergies, the 
hyposensitisation treatment of allergic rhinitis or bronchial asthma can also alleviate the 
symptoms of food allergies (AWMF Guideline No. 061/011). 
 
3.4 Summary 
 
Annex lIIa to the EU Directive 2000/13/EC on the labelling of foods lists the foods which 
trigger allergies and certain food intolerances the most often. These so-called main allergens 
must be listed on the labels of (pre-packaged or mainly processed) foods. They are gluten-
containing cereals (wheat, rye, barley, oats, spelt, kamut or hybrid strains of them), 
crustaceans, eggs, fish, peanuts, soybeans, milk, shell fruit (almonds, hazelnuts, walnuts, 
   Page 16 of 29 
Federal Institute for Risk Assessment 
cashew nuts, pecan nuts, brazil nuts, pistachios, macadamia nuts, Queensland nuts), celery, 
mustard, sesame seeds and products derived from them as well as sulphur dioxide and 
sulphites at concentrations of more than 10 mg/kg or 10 mg/l expressed as SO2. As some 
derivatives of known food allergens may not trigger allergic reactions, some exceptions have 
been formulated which are valid up to November 2007. 
 
This mandatory labelling does not apply to so-called “loose goods” like bakery products, 
sausage and cheese which are sold to the consumer over the counter (bakeries, butchers 
shops, canteens and at open air weekly markets). Foods in pre-packages which are 
produced at the point of sale for immediate sale to the consumer and are handed over to 
consumers, do not have to be similarly labelled either (like freshly prepared salads, which are 
packaged in the shop and handed to the consumer by sales staff). 
 
Appropriate measures should be taken to prevent unintentional contamination with allergenic 
components subject to mandatory labelling which may occur during the production process 
(cross-contamination) of foods. This includes appropriate rinsing as well as the use of 
separate conduction systems and production segments to prevent/avoid carry over. Because 
of the different products and production processes, it is, however, difficult to apply the 
principles of good manufacturing practice or technological unavoidability when assessing 
these measures. 
 
Some spices, herbs and peas have an allergenic potential which, however, seems to be less 
relevant in terms of numbers than the main allergens already mentioned in Annex IIIa to the 
Food Labelling Regulation (EU Directive 2000/13/EC Annex IIIa). 
 
Individuals who are allergic to birch pollen are more at risk of developing additional 
intolerances to various foods – like apples, cherries, brazil nuts, celery, hazelnuts, kiwis, 
oranges, tomatoes, carrots, peach or soya (cross-reactivity with the triggering of an oral 
allergy syndrome). A similar situation was observed in conjunction with an existing allergy to 
latex and foods like avocados, potatoes, bananas and tomatoes. Patients who have been 
diagnosed as having a birch pollen allergy, should be informed by their attending physician 
about the possibility of a cross-reaction to a series of foods. Information on the various 
aspects of a birch pollen allergy, including possible cross-allergies that can cause an oral 
allergy syndrome (OAS) of varying degrees of severity, is available in various forms. 
Attending GPs, specialist associations and patient associations active in this area should 
provide sufferers with general and individual information. 
 
3.5 Additives 
 
3.5.1 Prevalence 
 
Varying information is available on the prevalence of intolerance to food additives. Based on 
several studies the Scientific Committee on Food (SCF) for the European Commission came 
to the conclusion in 1981 that between 0.03 and 0.15% of the population are affected (SFC, 
1982). In other studies from Holland (Jansen et al., 1994), Denmark (Fuglsang et al., 1993; 
Madsen 1994) and the United Kingdom (Young et al., 1994), the prevalence of intolerance to 
additives was 0.13%, 1% and 0.026% respectively (SCF 1995). There are various reasons 
why prevalence can vary so markedly (Madsen 1994, EFSA 2004). The exact diagnosis of 
intolerance is not easy. Unlike the detection of real allergies, there are no simple blood or 
skin tests for the detection of pseudo-allergies. The prevalence of intolerance reactions to 
additives can only be reliably determined in extensive, placebo-controlled, double blind oral 
provocation tests. These requirements are only met by a few studies (Simon 2003). 
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Furthermore, specific groups like asthmatics or patients with urticaria or angioedemas were 
frequently examined who have a special sensitivity and are already undergoing medical 
treatment for corresponding symptoms. The results of studies of this kind can only be 
transferred in a limited manner to the overall population. Differing data on the prevalence of 
intolerance to additives can, therefore, be attributed to differences in the respective test 
populations but also to methodological difficulties in detecting pseudo-allergic reactions. 
 
3.5.2  Examples of relevant additives 
 
According to Kreft et al. (1995) and Simon (2003), some examples of additives mentioned in 
conjunction with pseudo-allergic reactions are: 
 
the preservatives:  
? sorbic acid and sorbates (E200-E203), 
? sodium, potassium or calcium benzoates (E211-E213), 
? parahydroxybenzoic acid esters (E214-E219) and sulphites (E220-E228), 
 
the antioxidants:  
? butylated hydroxy-anisol (BHA, E320) and butylated hydroxytoluene (BHT, E321), 
 
the dyes:  
? tartrazine (E102), 
? sunset yellow S (E110), 
? amaranth (E123), 
? cochineal red A (E124), 
? erythrosine (E127), 
? patent blue V (E131) and indigo carmine I (E132) 
 
the flavour-enhancer: 
? monosodium glutamate (E621). 
 
Sulphites 
Adverse reactions to sulphites have been described in detail by the EFSA Scientific Panel on 
Dietetic Products, Nutrition and Allergies NDA (EFSA 2004). Sulphites are used as 
preservatives (E220-E228). They do, however, also occur naturally in foods as a 
consequence of fermentation processes, for instance in wine. They may be formed during 
the digestion of sulphur-containing amino acids, too. In 1994 SCF established an ADI 
(Acceptable Daily Intake) of between 0 and 0.7 mg SO2/kg body weight. However, it stressed 
that compliance with this ADI did not mean that intolerance reactions like asthma induced 
through sulphite could be ruled out. While no information is available on the prevalence of 
intolerance to sulphites in the general population, data are available for asthma sufferers 
from various oral provocation studies indicating a range of between 4 % and 66 % (EFSA 
2004). The main intolerance reactions are bronchial spasms which may occur within a few 
minutes of eating sulphite-containing foods. Other effects were also observed, too. The 
pathogenesis has not been clearly elucidated. Immune-mediated and non immune-mediated 
mechanisms are under discussion whereby the NDA Panel is of the opinion that the 
existence of immune-mediated mechanisms is very unlikely (EFSA 2004). According to 
Directive 2003/89/EC foods containing concentrations of more than 10 mg/kg or 10 mg/l 
(expressed as SO2) of sulphur dioxides or sulphites must be correspondingly labelled. This 
value is based on the detection limit of the available methods for the determination of sulphur 
dioxide and sulphites. A threshold for intolerance reactions induced by sulphites is unknown; 
it could be lower than 10 mg/kg. 
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Tartrazine 
In the past the dye tartrazine (E102) has frequently been linked to an asthma-inducing effect. 
According to Simon (2003) however, sensitivity to tartrazine in asthmatic patients is 
extremely unusual. Reports that up to 50 % of asthmatics who are sensitive to aspirin are 
also sensitive to tartrazine could not be confirmed in placebo-controlled, double blind studies 
(Simon 2003). 
 
Monosodium glutamate 
Monosodium glutamate, used as a flavour enhancer (E621), also occurs naturally in foods. It 
is linked to a series of symptoms. Since reports in the 1960s about intolerance reactions after 
eating glutamate-containing dishes in Chinese restaurants, they are also called “China 
Restaurant Syndrome” or “Sodium Glutamate Symptom Complex”. Glutamates have been 
evaluated several times by the expert committees JECFA (Joint FAO/WHO Expert 
Committee on Food Additives) and SCF and accepted for use in foods. These evaluations 
also took into consideration the possible occurrence of intolerance (WHO 1987, SCF 1991). 
An expert body of the Federation of American Societies for Experimental Biology (FASEB) 
assessed monosodium glutamate on behalf of the American Food and Drug Administration 
(FDA) and found that a low, non-identified percentage of the population reacts to the 
consumption of monosodium glutamate with certain symptoms which are usually transient 
and not life-threatening. In these cases reactions had been observed under non-typical 
consumption conditions and after the intake of larger amounts of monosodium glutamate (3g 
or more) on an empty stomach and in the absence of foods. The 1995 FASEB report 
suspected that individuals suffering from severe asthma may be especially sensitive to 
glutamate (FDA 1995). This could not, however, be confirmed in placebo-controlled, double 
blind studies (Simon 2003). 
 
Cochineal, carmine and carminic acid 
In most cases intolerance reactions to additives are pseudo-allergic reactions whereby some 
additives can also lead to immune-mediated reactions (SCF 1995). IgE-mediated immune 
responses may, for instance, be triggered by cochineal extract (E120). The terms cochineal, 
carmine and carminic acid are sometimes used as synonyms but refer to different 
substances. Cochineal is the term used for the dried bodies of female chochineal scale 
insects, Dactylopius coccus Costa, which contain an alkali protein compound of carminic 
acid. The insects which originate from Central America are grown inter alia in the 
Mediterranean region. Water soluble carminic acid is made from extracts of the dried scale 
insect. Carmine is the lake made from precipitation with aluminium salts (Lück und Kuhnert 
1998). According to the purity criteria defined in Directive 95/45/EC these commercially 
available products also contain protein material from the insects. The use of cochineal as a 
colouring agent for foods has been assessed on several occasions by the expert bodies SCF 
and JECFA. In 1981 SCF established an acceptable daily intake (ADI) of between 0 and 
5 mg/kg body weight (SCF 1983). In 1982 JECFA came to the same conclusion (WHO 
1982). The allergenic potential was assessed by JECFA in 2001 (WHO 2001). There have 
been reports of reactions following occupational exposure, after skin contact and after 
consumption of foods containing these colours. The symptoms included urticaria, rhinitis, 
diarrhoea and anaphylaxis. There are several indications that proteins are the allergens, 
however, the structures of the proteins and the role of the protein-bound carminic acid in the 
allergic reaction are unknown (WHO 2001, Chung et al., 2001, Tabar et al., 2003). JECFA 
came to the conclusion that cochineal extract, carmine and possibly carminic acid in foods 
may lead to allergic, in some cases severe reactions (WHO 2001). 
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Mannitol 
An IgE-mediated mechanism was observed in one patient with a mannitol intolerance (E421) 
(Hedge and Venkatesh 2004). However, this finding is not likely to apply in general. 
 
3.5.3 Summary 
 
The occurrence of intolerance reactions to specific additives cannot be ruled out. The current 
labelling regulations do, however, mean it is possible for individuals to avoid foods in the 
case of a known intolerance to specific additives. 
 
3.5.4 Test requirements for food additives 
 
For food additives there are no mandatory test requirements. The EFSA Scientific Panel AFC 
that deals with food additives, flavourings, processing aids and materials in contact with food, 
looks to the recommendations of the Scientific Committee on Food of the European 
Commission (Guidance on submissions for food additive evaluations by the Scientific 
Committee on Food (SCF 2001). Studies on tests of immunotoxicity, allergenicity and 
intolerance reactions are touched on in the SCF recommendations, but are not part of the 
core studies that normally have to be carried out. A decision is taken on whether studies of 
this kind are necessary in each individual case. 
 
3.5.5 Test requirements for food enzymes (work ongoing) 
 
Standard legal provisions for food enzymes are to be adopted in the EU in the foreseeable 
future. At the same time, guidelines are to be published for the testing and evaluation of food 
enzymes. These guidelines are currently being elaborated by the AFC Scientific Panel of 
EFSA (with the participation of scientists from BfR). They are also to contain requirements for 
testing for allergenic potential which will probably be based on the recommendations for the 
testing and evaluation of new proteins in genetically modified plants (EFSA 2004, see 3.6). 
BfR is of the opinion that the tests proposed are, in principle, helpful but does draw attention 
to the fact that the tests do not permit a definite statement about allergenicity of a protein in 
the case of oral intake but allow for an assessment of the allergenic potential. In principle, 
there is a need to develop further in vitro tests and animal models which, after successful 
validation, can refine or replace the range of methods currently available for assessing the 
allergenic potential. 
 
Scientists agree that enzymes can trigger allergies in conjunction with inhalation and dermal 
exposure. This is primarily seen as a risk for individuals who are exposed to concentrated 
levels of enzymes at the workplace, for instance during production and use in the food-
processing industry. There are no confirmed cases in which the consumption of enzyme-
treated foods led to a sensitisation of consumers. However, it cannot be ruled out that 
allergic reactions may occur because of an earlier sensitisation (e.g. at the workplace) or 
because of cross-reactions. 
 
3.6 Assessment of the allergenic potential of foods derived from genetically modified 
plants 
 
In the case of foods derived from genetically modified plants the allergenic potential can be 
influenced by the introduction of new proteins but also by changes in the endogenous protein 
pattern. The following comments describe the procedure currently used by the EFSA 
Scientific Panel on Genetically Modified Organisms when assessing the allergenic potential 
(EFSA 2004). It is based on recommendations of expert groups of the World Health 
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Organisation and Food and Agriculture Organisation (WHO/FAO) and of the Codex 
Alimentarius Commission (CAC) (WHO/FAO 2001; CAC 2003). 
 
3.6.1 Allergenicity of new proteins 
 
Allergenicity is not a fully predictable inherent property of a protein as it is also influenced by 
the genetic background of the respective individual. There are no validated test methods to 
predict the allergenicity of a protein after oral intake. At the present time, a combination of 
different test methods is used to obtain various pieces of information which together allow an 
assessment of allergenic potential. The assessment is mainly based on comparisons of the 
protein with known allergens, on  information on the allergenicity of the organism that was 
the donor of the genetic material used and on the results of immunological in vitro tests. 
 
First of all a test for sequence homologies and / or structural similarities with known allergens 
is to be carried out. Bioinformatic analyses, in which the amino acid sequence of the protein 
in question is compared section by section with the sequences of known allergens stored in 
databases, can identify identities or similarities with linear IgE-binding epitopes. However, 
this method cannot be used to identify any epitopes which are formed by non-linear amino 
acids sequences (conformation epitopes) (Wal 1999). 
 
A second step examines – with the help of immunological in vitro methods like immunoblot, 
RAST (Radio-Allergo-Sorbent-Test) or ELISA (Enzyme-Linked Immuno Sorbent Assay) – 
whether the protein is bound by specific IgE antibodies from sera of allergic patients. The 
procedure depends on whether the corresponding gene introduced into the plant comes from 
an allergenic or non-allergenic organism. 
 
If the donor organism is considered allergenic but no sequence homology of the protein to a 
known allergen was demontrated, then specific serum screening should be undertaken. For 
this purpose sera from individuals who are sensitised to the donor organism are needed. In 
the case of a positive result the new protein may then be considererd very likely to be 
allergenic. If, by contrast, there is no IgE binding, additional studies should be conducted 
(see below). 
 
If the donor organism is not known to be allergenic, but there are indications of a sequence 
homology to a known allergen, specific serum screening should be conducted with sera from 
patients who are sensitised to this allergen. Furthermore, additional tests should be 
conducted. 
 
One recommended additional study involves testing the stability of the protein to the 
digestive enzyme pepsin in simulated gastric fluid (SGF). Some typical food allergens have 
proved to be relatively stable in this test; by contrast non-allergenic proteins are normally 
degraded within seconds (Metcalfe et al., 1996). However, no absolute congruence exists 
(Fu et al., 2002). Furthermore, targeted serum screening can be undertaken. For this sera of 
individuals are needed who are sensitised to foods broadly related to the donor organism of 
the genetic material. The use of this method and of specific serum screening is, however, 
constrained by the limited availability of suitable sera. 
 
If the evaluation of the overall findings indicates that the protein has allergenic potential, then 
risk management steps must be taken to ensure that individuals with a genetic predisposition 
for allergic disorders can avoid exposure. In line with the specific requirements for the 
labelling of foods derived from genetically modified organisms consumers’ attention must be 
drawn to the presence of the protein through appropriate labelling. 
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If the genetic material introduced into the plant comes from wheat, rye, barley, oats or related 
types of cereal, it should also be assessed whether the newly expressed protein plays a role 
in the triggering of gluten-induced enteropathy (coeliac disease) or in other enteropathies. 
 
3.6.2 Endogenous plant allergens 
 
If the unmodified plant is known to be allergenic, like soybean, or soybean derived foods, it 
should also be examined whether the endogenous allergen pattern was changed through the 
process of genetic modification. This is normally done by separating protein extracts 
obtained from the genetically modified plants using SDS polyacrylamide gel electrophoresis 
and the detection of allergenic proteins in immunoblots using sera from individuals with an 
allergy to soybeans. In future, profiling techniques (proteomics) in conjunction with 
immunological detection methods could also be used for the qualitative and quantitative 
analysis of endogenous proteins and peptides with allergenic potential. 
 
3.6.3 Prevalence of allergies to foods derived from genetically modified organisms 
 
Up to now there have been no reports at all of an allergy triggered specifically by foods 
derived from genetically modified organisms. However, in two cases, an allergenic potential 
of foods derived from transgenic plants was identified in the safety assessment. Based on 
the safety assessment these organisms were excluded from use in food production. 
 
The allergen range of traditional soybeans was compared with transgenic varieties in a 
series of studies. Sten et al. examined 18 soya extracts (8 traditional and 10 genetically 
modified types) with serum samples from nine adults allergic to soybean. The immune test 
(RAST), histamine release ex vivo and also the skin test produced variable reaction patterns 
which, however, also occurred independently of the genetic modification (Sten et al., 2004). 
In the sera of children with allergic asthma with rhinitis or a food allergy to maize or 
soybeans, no differences were detected either regarding the reaction to conventional or 
genetically modified types (Batista et al., 2005). 
 
3.7 Novel foods 
 
The safety assessments of novel foods and food ingredients, which come under the scope of 
Regulation (EC) No. 258/97,are carried out in line with the guidelines of the Scientific 
Committee on Food (SCF) of the European Commission (European Commission 1997). It 
calls for an assessment of allergenic potential without, however, making any concrete 
proposals about the type of test. Given the great degree of heterogeneity of novel foods, the 
testing and assessments are always done on a case by case basis: 
 
? In the case of individual substances, simple and complex mixtures, the procedure is 
the same as for food additives. A decision must be taken in each individual case 
whether and how a test for allergenic potential should be carried out (see section 
3.5.4). 
 
? No concrete test requirements were formulated either for complex novel products, 
which also include traditional foods from non European countries. In principle, it is a 
problem that new allergies to food ingredients normally only occur after lengthy 
consumption (with the exception of cross-reactions). In any case, there are no 
validated test methods for predicting allergenicity after oral exposure. If specific sera 
from allergic individuals are available, possible cross-reactions to already known 
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allergens should be examined by using immunological methods like ELISA or 
Western Blot. 
 
3.8 Unanswered questions and the need for research 
 
Up to now, the question about a possible increase in food allergies could not be 
unequivocally answered up to now as there are no longitudinal studies on allergy prevalence. 
One way of overcoming this lack of data could be to repeat the Berlin allergy study. 
 
Nor has the question been clarified whether concentrations can be identified for food 
allergens which are below the threshold for allergy patients. Studies to establish threshold 
values for individual allergens would also be desirable for the labelling of foods. 
 
The procedure used for the safety assessment of foods derived from genetically modified 
plants (see section 3.6.1) is also suitable for identifying known allergens in a new host. 
However, this method is only suited to a limited degree for identifying new allergens or the 
modified immunogenic properties of known proteins. In principle, there is a need to develop 
other in vitro tests and animal models which – after successful validation – can supplement 
or replace the spectrum of methods for assessing allergenic potential that are currently 
available. 
 
In recent years, therefore, allergenicity test models have been developed on the basis of 
suitable experimental animals (Atherton et al., 2002; Kimber et al., 2003; Knippels et al., 
2003). They offer approaches to examine the sensitising potential of popular proteins. 
According to Prescott and Hogan the animal models must meet the following criteria 
(Prescott et al., 2006): 
 
? The animals should react with known symptoms to the standard allergens. 
? The animals should already be specifically sensitisable to the oral administration of 
low amounts of the test protein without adjuvants. 
? There should be both specific IgE formation as well as other TH2 cell responses. 
? The clinical picture of the reaction should correspond to the human allergy. 
? The animals should be easy to keep, show high reproduction rates and have never 
been fed the protein that is being tested. 
 
The Norwegian brown rat and Balb/c laboratory mice have proved to be particularly suitable. 
 
The animal models developed in recent years are suitable in principle not only for testing the 
allergenicity of proteins but also for testing the ability to induce other immunological 
responses and tolerance. However, they can only be used within the framework of safety 
assessment after successful standardisation and validation. 
 
There are still unanswered questions concerning the influence of thermal processing 
techniques on food allergenicity. Thermal processes do frequently reduce the allergenicity of 
foods. However, there have also been reports of increased allergenicity resulting from the 
roasting of peanuts (Maleki et al., 2003). The systemic clarification of the influence of thermal 
processes on the allergenicity of individual allergens down to clinical end points would be 
desirable. Furthermore, it would be sensible to analyse the critical control points of 
production processes in order to minimise contamination with allergens by developing quality 
concepts. 
   Page 23 of 29 
Federal Institute for Risk Assessment 
 
4 References 
 
Atherton KT, Dearman RJ, Kimber I (2002): Protein allergenicity in mice: a potential 
approach for hazard identification. Ann N Y Acad Sci., May, 964:163-71. Review.  
 
Ballmer-Weber BK, Wüthrich B (2001): Die Nahrungsmittelallergie und ihre diätetische 
Behandlung. Aktuelle Ernährungsmedizin, 26: 196-201. 
 
Batista R, Nunes B, Carmo M, Cardoso C, Jose HS, de Almeida AB, Manique A, Bento L, 
Ricardo CP, Oliveira MM (2005): Lack of detectable allergenicity of transgenic maize and 
soya samples. J Allergy Clin Immunol, Aug, 116(2):403-10.  
 
Besler M (2001): Auswahl wichtiger Lebensmittelallergene für die Kennzeichnung auf 
Fertigpackungen. Ernährungs-Umschau 48, Heft 1, S. 8-12. 
 
BfR (2004): Gesundheitsgefahren durch Tätowierungen und Permanent make-up. 
Stellungnahme vom 22. März 2004. 
 
BfR (2006): „Gesundheitliche Bewertung von Textilhilfsmitteln und -farbmitteln“ der 
Arbeitsgruppe „Textilien“ des BfR, Bericht zur 12. Sitzung vom 08. März 2006. 
Boden M, Dadswell R, Hattersley S (2005): Review of statutory and voluntary labelling of 
food allergens. Proceedings of the Nutrition Society 64, Nr. 4, 475-480. 
 
Burks W, Ballmer-Weber BK (2006): Review: Food allergy. Mol. Nutr. Food Res. 50, 595-
603. 
 
Chung K, Baker JR Jr, Baldwin JL, Chou A (2001): Identification of carmine allergens among 
three carmine allergy patients. Allergy 56 (1): 73-77. 
 
Codex Alimentarius Commission (2003): Codex Principles and Guidelines on Foods Derived 
from Biotechnology, Joint FAO/WHO Food Standards Programme, Food and Agriculture 
Organisation, Rome, Italy. 
 
Department of Health and Human Services (2006): The health consequences of involuntary 
exposure to tobacco smoke. A Report of the Surgeon General. Website: 
http://www.surgeongeneral.gov/library/secondhandsmoke/report/fullreport.pdf. 
 
DGE (2002): Info, Fachinformationen der Deutschen Gesellschaft für Ernährung e.V., 
01/2002, Seiten 5 ff. 
 
DGE (2005): Info, Fachinformationen der Deutschen Gesellschaft für Ernährung e.V., 
09/2005, Seiten 136-137. 
 
 
EFSA (2004): Opinion of the Scientific Panel on Dietetic Products, Nutrition and Allergies on 
a request from the Commission relating to the evaluation of allergenic foods for labelling 
purposes (adopted on 19 February 2004), The EFSA Journal 32: 1-197, 
http://www.efsa.eu.int/science/nda/nda_opinions/341_en.html 
 
EFSA (2005): Opinion of the Scientific Panel on Dietetic Products, Nutrition and Allergies on 
a request from the Commission related to the evaluation of lupin for labelling purposes, 
   Page 24 of 29 
Federal Institute for Risk Assessment 
Request No. EFSA-Q-2005-086, adopted on 6 December 2005, The EFSA Journal (2005) 
302, 1-11, http://www.efsa.eu.int/science/nda/nda_opinions/catindex_en.html. 
 
EFSA (2006): Opinion of the Scientific Panel on Dietetic Products, Nutrition and Allergies on 
a request from the Commission related to the evaluation of molluscs for labelling purposes, 
Request No. EFSA-Q-2005-084, adopted on 15 February 2006, The EFSA Journal (2006) 
327, 1-25, http://www.efsa.eu.int/science/nda/nda_opinions/catindex_en.html. 
 
EFSA (2006): Opinion of the Scientific Panel on Dietetic Products, Nutrition and Allergies on 
a request from the Commission related to the tolerable upper intake level for nickel, adopted 
on 25 January 2006. 
 
Ellman LK, Chatchatee P, Sicherer SH, Sampson HA (2002): Food hypersensitivity in two 
groups of children and young adults with atopic dermatitis evaluated a decade apart. Pediatr 
Allergy Immunol 13: 295-298. 
 
European Commission (1997): Commission Recommendation of 29 July 1997 concerning 
the scientific aspects and the presentation of information necessary to support applications 
for the placing on the market of novel food ingredients and the preparation of initial 
assessment reports under Regulation (EC) No. 258/97 of the Euroepan Parliament and of 
the Council (97/618/EC), Official Journal of the European Communities L 253, 1-36. 
 
European Food Safety Authority (2004): Guidance Document of the Scientific Panel on 
Genetically Modified Organism for the Risk Assessment of Genetically Modified Plants and 
Derived Food and Feed, The EFSA Journal 99, 1-94. 
 
Faeste CK, Lovik M, Wiker HG, Egaas E (2004): A case of peanut cross-allergy to lupine 
flour in a hot dog bread. Int. Arch. Allergy Immunol. 135 Nr. 1: 36-39. 
 
FDA (1995): US Food and Drug Administration. FDA and Monosodium Glutamate (MSG), 
FDA Backgrounder, http://vm.cfsan.fda.gov/~Ird/msg.html 
 
Fu T-J, Abbott UR, Hatzos C (2002): Digestibility of food allergens and non-allergenic 
proteins in simulated gastric fluid and simulated intestinal fluid – a comparative study. 
Journal of Agricultural and Food Chemistry 50, 7154-7160. 
 
Fuglsang G, Madsen C, Saval P, Osterballe O (1993): Prevalence of intolerance to food 
additives among Danish school children. Pediatric Allergy and Immunology 4: 123-129. 
 
Gilissen LJWJ, Bolhaar STH, Matos CI, Rouwendal GJA, Boone MJ, Krens FA, Zuidmeer L, 
van Leeuwen A, Akkerdaas J, Hoffmann-Sommergruber K, Knulst AC, Bosch D, van de 
Weg, WE, van Ree R (2005): Silencing the major apple allergen Mal d 1 by using the RNA 
interference approach. J Allergy Clin Immunol 115: 364-369. 
 
Halken S (2004): Prevention of allergic disease in childhood: clinical and epidemiological 
aspects of primary and secondary prevention. Pediatr Allergy Immunol 15 (Suppl 16): 9-32. 
 
Hatch KL, Maibach HI (1995): Textile dye dermatitis, J Am Acad Dermatol 32, 631-639. 
 
Hauer A (2006): Kuhmilchallergie. Immunmechanismen und klinische Manifestationen. 
Monatsschr Kinderheilkd 154: 406-416. 
 
   Page 25 of 29 
Federal Institute for Risk Assessment 
Hegde VL, Venkatesh YP (2004): Anaphylaxis to excipient mannitol: evidence for an 
immunoglobulin E-mediated mechanism. Clinical & Experimental Allergy 34 (10): 1602-1609.  
 
Hermann-Kunz E (2000) Allergische Krankheiten in Deutschland. Ergebnisse einer 
repräsentativen Studie. Bundesgesundheitsblatt 43, 400-406. 
 
Jansen JJ, Kardinaal AF, Huijbers G, Vlieg-Boerstra BJ, Martens BP, Ockhuizen T (1994): 
Prevalence of food allergy and intolerance in the adult Dutch population. The Journal of 
Allergy and Clinical Immunology 93 (2): 446-456. 
 
Jensen CS, Lisby S, Baadsgaard O, Volund A, Menne T (2002): Decrease in nickel 
sensitization in a Danish schoolgirl population with ears pierced after implementation of a 
nickel-exposure regulation, Br J Dermatol 146, 636-642. 
 
Johansson SGO, Hourihane JOB, Bousquet J, Bruijnzeel-Koomen C, Dreborg S, Haahtela T, 
Kowalski ML, Mygind N, Ring J, van Cauwenberge P, van Hage-Hamsten M, Wüthrich B 
(2001): A revised nomenclature for allergy. An EAACI position statement from the EAACI 
nomenclature task force. Allergy 56: 813-824. 
 
 
Johansson SG, Bieber T, Dahl R, Friedmann PS, Lanier BQ, Lockey RF, Motala C, Ortega 
Martell JA, Platts-Mills TA, Ring J, Thien F, van Cauwenberge P, Williams HC 
(2004):Revised nomenclature for allergy for global use: report of the Nomenclature Review 
Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol 113: 
832-836. 
 
Johansson SGO, Haahtela T (2004): World Allergy Organization guidelines for prevention of 
allergy and allergic asthma. Int Arch Allergy Immunol 135: 83-92. 
 
Kimber I, Dearman RJ, Penninks AH, Knippels LM, Buchanan RB, Hammerberg B, Jackson 
HA, Helm RM (2003): Assessment of protein allergenicity on the basis of immune reactivity: 
animal models. Environ Health Perspect, Jun, 111(8):1125-30. Review.  
 
Knippels LM, Penninks AH (2003): Assessment of the allergic potential of food protein 
extracts and proteins on oral application using the brown Norway rat model. Environ Health 
Perspect, Feb, 111(2):233-8.  
 
Kreft D, Bauer R, Goerlich (1995): Nahrungsmittelallergene: Charakteristika und 
Wirkungsweisen. Walter de Gruyter, Berlin, New York. 
 
Lorenz AR, Reese G, Haustein D, Vieths S (2001): Versteckte Allergene in Lebensmitteln - 
noch immer ein Problem. Bundesgesundheitsblatt - Gesundheitsforschung - 
Gesundheitsschutz, 44, Nr. 7, S. 666-675. 
 
Lück E und Kuhnert P (Hrsg) (1998): Lexikon Lebensmittelzusatzstoffe, 2. Auflage, Behr, 
Hamburg. 
 
Madsen C (1994): Prevalence of food additive intolerance. Human and Experimental 
Toxicology 13 (6): 393-399. 
 
   Page 26 of 29 
Federal Institute for Risk Assessment 
Maleki SJ, Viquez O, Jacks T, Dodo H, Champagne ET, Chung SY, Landry SJ (2003): The 
major peanut allergen, Ara h 2, functions as a trypsin inhibitor, and roasting enhances this 
function.J Allergy Clin Immunol, Jul; 112(1):190-5. 
 
Metcalfe DD, Astwood JD, Townsend R, Sampson HA, Taylor SL, Fuchs RL (1996): 
Assessment of the Allergenic Potential of Foods Derived from Genetically Engineered Crop 
Plants, Critical Reviews in Food Science and Nutrition 36 (Supplement), 165-186. 
 
Muraro A, Dreborg S, Halken S, Host A, Niggemann B, Aalberse R et al. (2004a, b, c): 
Dietary prevention of allergic diseases in infants and small children. Part I: Immunologic 
background and criteria for hypoallergenicity. Part II: Evaluation of methods in allergy 
prevention studies and sensitization markers. Definitions and diagnostic criteria of allergic 
diseases. Part III: Critical review of published peer-reviewed observational and interventional 
studies and final recommendations. Pediatr Allergy Immunol 15: 103-111; 196-205; 291-307. 
 
Niggemann B, Staden U, Rolinck-Werninghaus C, Beyer K (2006): Specific oral tolerance 
induction in food allergy. Allergy 61: 808-811. 
 
Oppel T, Schnuch A (2006): Häufigste Auslöser allergischer Kontaktekzeme. Deut Med 
Wochenschr 131, 1584-1589. 
 
Osterballe M, Hansen TK, Mortz CG, Host A, Bindslev-Jensen C (2005): The prevalence of 
food hypersensitivity in an unselected population of children and adults. Pediatr Allergy 
Immunol 16: 567-573. 
 
Penders J, Thijs C, Vink C, Stelma FF, Snijders B, Kummeling I, van den Brandt PA, 
Stobberingh EE (2006): Factors influencing the composition of the intestinal microbiota in 
early infancy. Pediatrics 118: 511-521. 
 
Pereira B, Venter C, Grundy J, Clayton B, Arshad SH, Dean T (2005): Prevalence of 
sensitization to food allergens, reported adverse reaction to foods, food avoidance, and food 
hypersensitivity among teenagers. J Allergy Clin Immunol 116: 884-892. 
 
Prescott VE, Hogan SP (2006): Genetically modified plants and food hypersensitivity 
diseases: usage and implications of experimental models for risk assessment. Pharmacol 
Ther, Aug, 111(2):374-83.  
 
Radcliffe M, Scadding G, Morrow Brown H (2005): Lupin flour anaphylaxis. Lancet 365:1360. 
 
Raithel M, Hahn EG, Baenkler HW (2002): Klinik und Diagnostik von 
Nahrungsmittelallergien. Deutsches Ärzteblatt, Jg. 99, Heft 12, C 599-605. 
 
Roehr CC, Edenharter G, Reimann S, Ehlers I, Worm M, Zuberbier T, Niggemann B (2004): 
Food allergy and non-allergic food hypersensitivity in children and adolescents. Clin Exp 
Allergy 34: 1534-1541. 
 
Rolinck-Werninghaus C, Staden U, Mehl A, Hamelmann E, Beyer K, Niggemann B (2005): 
Specific oral tolerance induction with food in children: transient or persistent effect on food 
allergy? Allergy 60: 1320-1322. 
 
Roux KH, Teuber SS, Sathe SK (2003): Tree nut allergens. Int. Arch. Allergy Immunol. 131, 
Nr. 4: 234-244. 
   Page 27 of 29 
Federal Institute for Risk Assessment 
 
Samartin S, Marcos A, Chandra RK (2000): Food hypersensitivity. Nutrition Research 21: 
473-497. 
 
SCF (1982): Report of the Scientific Committee for Food on the sensitivity of individuals to 
food components and food additives (Opinion expressed 22 October 1981). Commission of 
the European Communities. Reports of the Scientific Committee for Food, Twelfth Series, 
http://europa.eu.int/comm/food/fs/sc/scf/reports/scf_reports_12.pdf 
 
SCF (1983): Reports of the Scientific Committee for Food concerning Colouring Matters 
authorized for Use in Foodstuffs intended for Human Consumption. Commission of the 
European Communities. Reports of the Scientific Committee for Food, Fourteenth Series, 
1983, 47-61. http://europa.eu.int/comm/food/fs/sc/scf/reports/scf_reports_14.pdf 
 
SCF (1991): Reports of the Scientific Committee for Food (Twenty-fifth series). First series of 
food additives of various technological functions. Commission of the European Communities, 
http://europa.eu.int/comm/food/fs/sc/scf/reports/scf_reports_25.pdf 
 
SCF (1995): Report on adverse reactions to foods and food ingredients. European 
Commission, Reports of the Scientific Committee for Food (37th series), 
http://europa.eu.int/comm/food/fs/sc/scf/reports/scf_reports_37.pdf 
 
SCF (2001): Guidance on submissions for food additive evaluations by the Scientific 
Committee on Food (opinion expressed on 11 July 2001), 
http://europa.eu.int/comm/food/fs/sc/scf/out98_en.pdf 
 
SCHER (2006): Scientific Committee on Health and Environmental Risks, Opinion on the 
report “Emission of chemicals by air fresheners Tests on 74 consumer products sold in 
Europe” (BEUC report January 2005),  Adopted by the SCHER during the 9th plenary of 27 
January 2006, 
http://ec.europa.eu/health/ph_risk/committees/04_scher/docs/scher_o_026.pdf 
 
Schnuch A, Uter W, Geier F, Gefeller O (2002): Epidemiology of contact allergy: an 
estimation of morbidity employing the clinical epidemiology and drug utilisation research (CE-
DUR) approach. Contact Dermatitis 47, 32-39. 
 
Schnuch A, Geier J, Lessmann H, Uter W, Arnold R, Mackiewiecz, M (2004): 
Untersuchungen zur Verbreitung umweltbedingter Kontaktallergien mit Schwerpunkt im 
privaten Bereich, Forschungsbericht 29961219, Umweltbundesamt, Berlin.  
 
Siedentopp U (1997): Den Käse im Visier - Biogene Amine als Auslöser pseudoallergischer 
Reaktionen - Ernährungsbedingte Histaminosen ein immer häufigeres Praxisproblem. 
Zeitung für Umweltmedizin, 5. Jg, Heft 3, S. 149-150. 
 
Simon RA (2003): Adverse reactions to food additives. Current Allergy and Asthma Reports 
3 (1): 62-66. 
 
Smith WB, Gillis D, Kette FE (2004): Lupin: a new hidden food allergen. Med. J. Aust. 181 
Nr. 4: 219-220. 
 
Sosted H, Johansen JD, Andersen KE, Menne T. (2006): Severe allergic hair dye reactions 
in 8 children. Contact Dermatitis 54, 87-91. 
   Page 28 of 29 
Federal Institute for Risk Assessment 
 
Staden U, Rolinck-Werninghaus C, Beyer K, Niggemann B (2006): Spezifische orale 
Toleranzinduktion bei Nahrungsmittelallergie. Monatsschr Kinderheilkd 164: 432-438. 
 
Sten E, Skov PS, Andersen SB, Torp AM, Olesen A, Bindslev-Jensen U, Poulsen LK, 
Bindslev-Jensen C (2004): A comparative study of the allergenic potency of wild-type and 
glyphosate-tolerant gene-modified soybean cultivars. APMIS, Jan, 112(1):21-8. 
 
Straff W, Schnuch A (2006): Umweltbedingte Kontaktallergien. Bundesgesundheitsblatt 49, 
796-803. 
 
Strid J, Thomson M, Hourihane J, Kimber I, Strobel S (2004): A novel model of sensitization 
and oral tolerance to peanut protein. Immunology 113: 293-303. 
 
Tabar AI, Acero S, Arregui C, Urdanoz M, Quirce S (2003): Asma y alergia por el colorante 
carmín [Asthma and allergy due to carmine dye]. Anales del Sistema Sanitario de Navarra 26 
Suppl 2: 65-73. 
 
UBA (2006): Duftstoffe: Wenn Angenehmes zur Last werden kann. Hintergrundpapier April 
2006 http://www.umweltbundesamt.de/uba-info-presse/hintergrund/duftstoffe.pdf 
 
Venter C, Pereira B, Grundy J, Clayton CB, Arshad SH, Dean T (2006): Prevalence of 
sensitization reported and objectively assessed food hypersensitivity amongst six-year-old 
children: a population-based study. Pediatr Allergy Immunol 17: 357-363. 
 
Vickerstaff Joneja JM (1999): Oral Allergy Syndrome, Cross-reacting Allergens and Co-
occuring Allergies. Journal of Nutritional & Environmental Medicine 9, 289-303. 
 
Wal JM (1999): Assessment of allergic potential of (novel) foods, Nahrung 43, 168-174. 
 
WHO (1982): Joint FAO/WHO Expert Committee on Food Additives (JECFA), World Health 
Organization, WHO Food Additives Series 17: Carmines, 
http://www.inchem.org/documents/jecfa/jecmono/v17je07.htm 
 
WHO (1987): Toxicological evaluation of certain food additives. L-Glutamic acid and its 
ammonium, calcium, monosodium and potassium salts. WHO Food Additives Series, No. 22. 
World Health Organisation, Geneva, 
http://www.inchem.org/documents/jecfa/jecmono/v22je12.htm 
 
WHO (2001): Joint FAO/WHO Expert Committee on Food Additives (JECFA), World Health 
Organization, WHO FOOD ADDITIVES SERIES 46: COCHINEAL EXTRACT, CARMINE, 
AND CARMINIC ACID, http://www.inchem.org/documents/jecfa/jecmono/v46je03.htm 
 
WHO/FAO (2001): Evaluation of Allergenicity of Genetically Modified Foods, Report of a 
Joint FAO/WHO Expert Consultation of Allergenicity of Foods Derived from Biotechnology, 
22-25 January 2001, Rome, Italy. 
 
Wüthrich B, Mittag D, Ballmer-Weber BK (2004): Die Pizza: eine Quelle von unerwarteten 
Allergenen – anaphylaktische Reaktionen auf Lupinenmehl im Pizzateig und in einem 
Lebkuchen. Allergologie, Jahrgang 27, Nr. 12, S. 495-502. 
 
   Page 29 of 29 
Federal Institute for Risk Assessment 
Young E, Stoneham MD, Petruckevitch A, Barton J, Rona R (1994): A population study of 
food intolerance. Lancet 343: 1127-1130. 
 
Zuberbier T, Edenharter G, Worm M, Ehlers I, Reimann S, Hantke T, Roehr CC, Bergmann 
KE, Niggemann B (2004): Prevalence of adverse reactions to food in Germany - a population 
study. Allergy 59: 338-345. 
 
 
